3 Results for "

NIH-H460

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "NIH-H460" in MCE Product Catalog:

Cat. No.: HY-147695
CAS No.: 2426675-70-7
Target:  

c-Met/HGFR

Research Areas:  

Cancer

c-Met-IN-12 (compound 4r) is an orally active, potent and selective type II c-Met kinase inhibitor, with an IC50 of 10.6 nM. c-Met-IN-12 displays high inhibitory effects (inhibition rate > 80% in 1 μM) against AXL, Mer and TYRO3 kinases. c-Met-IN-12 can be used a scaffold for further kinase selectivity enhancement. c-Met-IN-12 shows antitumor efficacy .
loading...
    loading...
Cat. No.: HY-146884
CAS No.: 1446324-02-2
Target:  

c-Met/HGFR VEGFR

Research Areas:  

Cancer

MET kinase-IN-3 (compound 8) is an orally active and potent MET inhibitor, with an IC50 of 9.8 nM. MET kinase-IN-3 shows good and broad-spectrum antiproliferative activity against cancer cell lines .
loading...
    loading...
Cat. No.: HY-122275
CAS No.: 406228-58-8
Target:  

Bcl-2 Family

Research Areas:  

Cancer

A-371191 is a selective Bcl-XL antagonist with a Ki <0.5 μM, and also acts as a mitochondria-targeting agent and chemosensitizer. A-371191 restores the sensitivity of cancer cells overexpressing Bcl-XL to Cisplatin (HY-17394) and Doxorubicin (HY-15142A). A-371191 reduces tumor volume in mice with intraperitoneal tumors. A-371191 can be used in the research of acute myeloid leukemia .
loading...
    loading...